| Adult diffuse low-grade gliomas: 35-year experience at the Nancy France Neurooncology Unit T Obara, M Blonski, C Brzenczek, S Mézières, Y Gaudeau, C Pouget, ... Frontiers in oncology 10, 574679, 2020 | 65 | 2020 |
| Initial PCV chemotherapy followed by radiotherapy is associated with a prolonged response but late neurotoxicity in 20 diffuse low-grade glioma patients M Blonski, T Obara, C Brzenczek, C Pouget, C Dillier, M Meyer, L Lavigne, ... Frontiers in Oncology 12, 827897, 2022 | 15 | 2022 |
| Transcriptomic Study on Human Skin Samples: Identification of Two Subclasses of Actinic Keratoses H Dubois-Pot-Schneider, G Khairallah, C Brzenczek, F Plénat, F Marchal, ... International Journal of Molecular Sciences 24 (6), 5937, 2023 | 4 | 2023 |
| Integrating digital gait sensor data with metabolomics and clinical data to predict clinically relevant outcomes in Parkinson's disease C Brzenczek, Q Klopfenstein, T Hähnel, H Fröhlich, E Glaab npj Digital Medicine 7 (235), 2024 | 3* | 2024 |
| Multi-factor modelling for deision supportin chemotherapy treatment of diffuse low-grade glioma brain tumours C Brzenczek < bound method Organization. get_name_with_acronym of< Organization …, 2021 | | 2021 |
| Modélisation multi-facteurs pour l’aide à la décision dans le traitement par chimiothérapie des tumeurs cérébrales de type gliome diffus de bas grade C Brzenczek Université de Lorraine, 2021 | | 2021 |
| An original MRI-based method to quantify the Diffuse Low-Grade Glioma brain infiltration C Brzenczek, S Mézières, Y Gaudeau, M Blonski, F Rech, T Obara, ... 2020 Tenth International Conference on Image Processing Theory, Tools and …, 2020 | | 2020 |
| Docteur de l’Université de Lorraine C BRZENCZEK | | |
